Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT02085980Not ApplicableCompleted

Clinical Investigation to Assess the Safety and Efficacy of the Laser for the Treatment of Vulvovaginal Atrophy

Role: lead

NCT03665584Not ApplicableCompleted

MonaLisa Touch Laser for the Treatment of Vulvar Lichen Sclerosus

Role: collaborator

NCT01859611Not ApplicableCompleted

TriActive+ Radiofrequency (RF) for Non-Invasive Treatment of Wrinkles and Rhytides

Role: lead

All 3 trials loaded